Shane Maltbie is the Vice President of Finance at TScan Therapeutics.  Shane has over 15 years of experience leading finance and accounting teams.  Prior to joining TScan, Shane was the Vice President of Finance at Axcella Health Inc. where he was influential in four of Axcella’s financings, including its initial public offering in May 2019.   Before joining Axcella, Shane was the Director of Technical Accounting at Parexel International.  Previously, Shane began his career in the audit practice of Deloitte & Touche.

Shane is a licensed CPA in the Commonwealth of Massachusetts and holds a B.S. in Accounting and Business Administration from Hartwick College and a M.S.A from Northeastern University.

When he’s away from TScan he can be found on the mountain skiing with his family or out on the lake boating.